Analysing the role of endogenous matrix molecules in the development of osteoarthritis
- 18 September 2009
- journal article
- review article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 90 (5), 463-479
- https://doi.org/10.1111/j.1365-2613.2009.00676.x
Abstract
Osteoarthritis (OA) is the most common form of arthritis worldwide. In this condition, damage to the extracellular matrix (ECM) of cartilage occurs, resulting in joint destruction. Factors mediating cartilage damage include mechanical injury, cytokine and superoxide release on a background of genetic susceptibility and obesity. Studies of arthritic cartilage show increased production of ECM molecules including type II collagen, cartilage oligomeric matrix protein, fibronectin (FN) and fibromodulin. Recent reports suggest that ECM proteins may become endogenous catabolic factors during joint damage. Activation of pro-inflammatory pathways by ECM proteins has led to their description as damage-associated molecular patterns (DAMPs). The ECM proteins involved include fibromodulin, which activates the complement pathway and may promote the persistence of joint inflammation. Fragmentation of type II collagen, FN and hyaluronan reveals cryptic epitopes that stimulate proteolytic enzymes including matrix metalloproteinases and aggrecanases (ADAMTSs - a disintegrin and metalloproteinase with thrombospondin type 1 motifs). Proteolytic fragments also stimulate the release of nitric oxide, chemokines and cytokines and activation of the MAP kinases. Reports are emerging that the receptors for the fragments described involve interaction with integrins and toll-like receptors. In this review the contribution of endogenous ECM molecules to joint destruction will be discussed. A deeper understanding of the pathways stimulated by endogenous ligands could offer potential avenues for novel therapies in the future.Keywords
This publication has 137 references indexed in Scilit:
- Mechanical Injury and Cytokines Cause Loss of Cartilage Integrity and Upregulate Proteins Associated with Catabolism, Immunity, Inflammation, and RepairMolecular & Cellular Proteomics, 2009
- Membrane type-1 matrix metalloproteinase is induced following cyclic compression of in vitro grown bovine chondrocytesOsteoarthritis and Cartilage, 2007
- Hip passive range of motion and frequency of radiographic hip osteoarthritis in former elite handball playersBritish Journal of Sports Medicine, 2005
- Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytesOsteoarthritis and Cartilage, 2005
- Increased Urinary Concentration of Collagen Type II C-Telopeptide Fragments in Patients with OsteoarthritisPathobiology, 2004
- Characterization of Type XI Collagen-Glycosaminoglycan InteractionsPublished by Elsevier BV ,2001
- Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.JCI Insight, 1997
- Splicing patterns of fibronectin mRNA from normal and osteoarthritic human articular cartilageOsteoarthritis and Cartilage, 1995
- Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin b and an inhibitor of matrix metalloproteinases. evidence for two converging pathways of chondrocyte‐mediated proteoglycan degradationArthritis & Rheumatism, 1993
- Genetic Linkage of a Polymorphism in the Type II Procollagen Gene (COL2A1) to Primary Osteoarthritis Associated with Mild ChondrodysplasiaNew England Journal of Medicine, 1990